Patient-Provider Discussions on Lung Cancer Screening: Insights From the Health Information National Trends Survey (HINTS)

Background Lung cancer risk is significantly elevated in individuals with chronic lung diseases (CLDs), including asthma, emphysema, and chronic bronchitis. Despite this, lung cancer screening (LCS) remains underutilized in this high-risk population. This study aimed to examine the factors associated with patient-provider discussions about LCS among adults with CLD. Methodology Using data from four cycles of the Health Information National Trends Survey (HINTS) from 2013 to 2022, we examined patient-provider communication patterns about LCS among respondents over the age of 50 years with a smoking history and CLD. Results Of the 828 eligible respondents, only 26.3% reported having discussed LCS with a healthcare provider. Older age, non-Hispanic ethnicity, and prior discussions about colorectal cancer screening were associated with higher rates of LCS conversations, while food insecurity significantly decreased the likelihood of such discussions. Notably, conversations peaked in 2020 but declined sharply by 2022, potentially reflecting disruptions in preventive care due to the COVID-19 pandemic. Conclusions Our findings highlight the persistent communication gap around LCS in CLD patients, emphasizing the need for improved provider engagement and awareness. Socioeconomic disparities and limited preventive care access continue to influence screening uptake. Interventions that promote shared decision-making, address social determinants of health, and integrate LCS discussions into routine care could enhance early detection and reduce lung cancer-related morbidity and mortality in this vulnerable population.